Heterologous versus homologous primary and booster <scp>COVID</scp>‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicenter, case–control study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicenter, case–control study

Published:2023-02-15 Issue:6 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Mercuri Santo Raffaele¹,Pacifico Alessia²^ORCID,Malagoli Piergiorgio³,Bianchi Vittoria Giulia¹,Pregliasco Fabrizio Ernesto⁴⁵,Del Fabbro Massimo⁴⁶⁷,Damiani Giovanni¹⁶⁷^ORCID

Affiliation:

1. Unit of Dermatology IRCCS San Raffaele Hospital Milan Italy

2. Clinical Dermatology Department San Gallicano Dermatological Institute, IRCCS Rome Italy

3. Dermatology Unit Azienda Ospedaliera San Donato Milanese Milan Italy

4. IRCCS Ospedale Galeazzi‐Sant'Ambrogio Milan Italy

5. Department of Biomedical Sciences for Health University of Milan Milan Italy

6. Department of Biomedical, Surgical and Dental Sciences University of Milan Milan Italy

7. Italian Center of Precision Medicine and Chronic Inflammation Milan Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18943

Reference5 articles.

1. COVID ‐19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED‐ZONE declaration

2. SARS‐CoV ‐2 vaccination and practical points in psoriasis patients: A narrative review

3. Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome

4. Homologous and Heterologous Covid-19 Booster Vaccinations

5. Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Psoriasis Flares: A Narrative Review;Psoriasis: Targets and Therapy;2024-05

2. The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study;Dermatologic Therapy;2023-12-26

3. Impact of COVID-19 on Medical Care Conduct and Psychological Burden Among Patients With Psoriasis: Real-World Data From a Tertiary Hospital in China;International Journal of Dermatology and Venereology;2023-05-05

4. Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis;Psoriasis: Targets and Therapy;2023-04

5. Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study;Dermatology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3